KR20100029369A - Method for preparing green tea saponin, 21-o-angeloyltheasapogenol e3 - Google Patents

Method for preparing green tea saponin, 21-o-angeloyltheasapogenol e3 Download PDF

Info

Publication number
KR20100029369A
KR20100029369A KR1020080088127A KR20080088127A KR20100029369A KR 20100029369 A KR20100029369 A KR 20100029369A KR 1020080088127 A KR1020080088127 A KR 1020080088127A KR 20080088127 A KR20080088127 A KR 20080088127A KR 20100029369 A KR20100029369 A KR 20100029369A
Authority
KR
South Korea
Prior art keywords
enzyme
angeloyltheasapogenol
acid
green tea
angeloylthiasapogenol
Prior art date
Application number
KR1020080088127A
Other languages
Korean (ko)
Other versions
KR101415995B1 (en
Inventor
박준성
박혜윤
김동현
김덕희
김한곤
Original Assignee
(주)아모레퍼시픽
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)아모레퍼시픽 filed Critical (주)아모레퍼시픽
Priority to KR1020080088127A priority Critical patent/KR101415995B1/en
Publication of KR20100029369A publication Critical patent/KR20100029369A/en
Application granted granted Critical
Publication of KR101415995B1 publication Critical patent/KR101415995B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE: A method for preparing a green tea saponin 21-O-angeloyltheasapogenol E3 is provided to massively produce 21-O-angeloyltheasapogenol E3 through hydrolysis using microorganism. CONSTITUTION: A method for preparing 21-O-angeloyltheasapogenol E3 comprises: a step of collecting extract containing saponin from plant seeds using eater or organic solvent; and a step of hydrolyzing the extract using acid, base, enzyme, or microorganism producing the enzyme to isolate the 21-O-angeloyltheasapogenol E3 of chemical formula 1. The plant seed is green tea seed. The acid is hydrochloric acid, sulfuric acid, nitric acid, or ethanol, methanol, or butanol thereof. The base is sodium hydroxide, or potassium hydroxide, or base, ethanol, methanol, or butanol thereof. The enzyme is glucosidase, arabinosidase, rhamnosidase, xylosidase, cellulose, hesperidinase, naringinase, [glucuronidase, pectinase, galactosidase, or amyloglucosidase.

Description

녹차 사포닌 21-O-안젤로일티아사포제놀 E3의 제조방법{Method for preparing green tea saponin, 21-O-angeloyltheasapogenol E3}Method for preparing green tea saponin 21-O-angeloylthiasapogenol E3 {Method for preparing green tea saponin, 21-O-angeloyltheasapogenol E3}

본 발명은 올레아난계 트리터페노이드 계열의 유도체로서 하기 화학식 1로 표현되는 녹차 사포닌 유도체 21-O-안젤로일티아사포제놀(21-O-angeloyltheasapogenol) E3를 제조하는 방법에 관한 것이다.The present invention relates to a method for producing a green tea saponin derivative 21-O-angeloyltheasapogenol E3 represented by the following formula (1) as an oleanan-based triterpenoid derivative.

Figure 112008063533811-PAT00002
Figure 112008063533811-PAT00002

녹차는 전 세계의 가장 오래된 역사를 가지고 있는 음료로, 최근 녹차에 대한 관심이 높아지면서 차의 성분과 그 약리 효과에 대한 연구가 많이 이루어지고 있다. 녹차는 다른 식품에 비하여 트레아민(threamine)과 폴리페놀(polyphenol)류가 다량 함유되어 있다. 녹차의 기능성분은 다엽중의 폴리페놀(polyphenol)류에 속하는 플라벤-3-올(flavan-3-ol)을 기본으로 하는 카테친(catechin)으로 (+)-카테친, (-)-에피카테친(epicatechin), (-)-에피갈로카테친-3-갈레이트(epigallocatechin-3-gallate), (-)-갈로카테친(gallocatechin) 등이 주성분인 것으로 알려져 있다. 특히 녹차에 들어 있는 폴리페놀류는 혈중 콜레스테롤을 저하시키고, 항산화작용, 항암작용, 해독작용, 항균작용, 충치예방작용, 노화억제작용, 미백효과 및 향기성분 등이 있는 것으로 보고되고 있다. 또한 녹차에 들어 있는 폴리페놀류는 통풍예방은 물론 과산화지질을 억제하고 노화를 지연시키며 중성지질의 생성을 억제하므로 비만을 방지하고 모세혈관의 저항력을 증진시킨다고 보고되고 있다.Green tea is the oldest drink in the world, and as the interest in green tea has recently increased, studies on the composition of tea and its pharmacological effects have been conducted. Green tea is higher in threamine and polyphenols than other foods. The functional ingredients of green tea are catechins based on flavan-3-ol, which belongs to polyphenols in the multileaf, and are (+)-catechin and (-)-epicatechin. (epicatechin), (-)-epigallocatechin-3-gallate, (-)-gallocatechin and the like are known to be the main ingredients. In particular, polyphenols contained in green tea have been reported to lower blood cholesterol, antioxidant, anticancer, detoxification, antibacterial, caries prevention, anti-aging, whitening and fragrance. In addition, polyphenols contained in green tea have been reported to prevent obesity and increase the resistance of capillaries by preventing gout peroxide, delaying aging and inhibiting the production of neutral lipids.

그러나, 이러한 다양한 효능을 가지고 있는 녹차는 대부분 잎을 사용하고 있으며 유사한 효능 물질을 함유하고 있는 녹차 씨는 재배 목적 외에 특별히 사용되고 있지 못하고 있다.However, most of the green teas having such various efficacy use leaves, and green tea seeds containing similar potent substances have not been specifically used for cultivation purposes.

이에 본 발명자들은 녹차로부터, 특히 특별한 용도로 사용되지 못하고 있는 녹차 씨로부터 생리활성이 뛰어난 아글리콘(aglycone) 타입의 녹차 사포닌 21-O-안젤로일티아사포제놀(21-O-angeloyltheasapogenol) E3을 대량생산 할 수 있는 방법을 연구한 결과 본 발명을 완성하게 되었다.Accordingly, the present inventors have found a large amount of aglycone-type green tea saponin 21-O-angeloyltheasapogenol E3 having excellent physiological activity from green tea, in particular, green tea seeds which are not used for special purposes. As a result of studying the production method, the present invention has been completed.

따라서, 본 발명은 아글리콘(aglycone) 타입의 녹차 사포닌 21-O-안젤로일티아사포제놀(21-O-angeloyltheasapogenol) E3를 제조하는 방법을 제공하는 것을 목적으로 하며, 특히 녹차 종자 추출물을 가수분해 하여 21-O-안젤로일티아사포제놀(21-O-angeloyltheasapogenol) E3를 생성시키고 이를 분리하여 제조하는 방법을 제공하는 것을 목적으로 한다.Accordingly, an object of the present invention is to provide a method for producing aglycone type green tea saponin 21-O-angeloyltheasapogenol E3, in particular, hydrolyzing green tea seed extract. The purpose of the present invention is to provide a method for producing 21-O-angeloyltheasapogenol E3 and isolating it.

상기한 목적을 달성하기 위하여, 본 발명은 식물 종자로부터 물 또는 유기용매를 이용하여 사포닌을 함유하는 추출물을 수득하는 제 1 단계; 및 상기 추출물을 산, 염기, 효소 또는 상기 효소를 생산하는 미생물을 이용하여 가수분해함으로써 21-O-안젤로일티아사포제놀(21-O-angeloyltheasapogenol) E3를 분리하는 제 2 단계;를 포함하는 21-O-안젤로일티아사포제놀 E3를 제조하는 방법을 제공한다.In order to achieve the above object, the present invention is a first step of obtaining an extract containing saponin from water or organic solvent from the plant seed; And a second step of separating 21-O-angeloyltheasapogenol E3 by hydrolyzing the extract with an acid, a base, an enzyme, or a microorganism producing the enzyme. 21-O-angeloyltheasapogenol E3 Provided is a method for preparing -O-angeloylthiasapogenol E3.

본 발명의 21-O-안젤로일티아사포제놀(21-O-angeloyltheasapogenol) E3을 제조하는 방법을 이용하면, 녹차 종자로부터 사포닌 추출물을 수득한 후, 산, 염기, 효소 또는 상기 효소를 생산하는 미생물을 이용한 가수분해방법을 통해 주요한 생리활성물질의 하나인 21-O-안젤로일티아사포제놀(21-O-angeloyltheasapogenol) E3를 대량으로 생산할 수 있다.Using the method for preparing 21-O-angeloyltheasapogenol E3 of the present invention, after obtaining saponin extract from green tea seed, the microorganism producing the acid, base, enzyme or the enzyme Through the hydrolysis method, 21-O-angeloyltheasapogenol E3, one of the main bioactive substances, can be produced in large quantities.

본 발명에 의한 하기 화학식 1로 표현되는 21-O-안젤로일티아사포제놀(21-O-angeloyltheasapogenol) E3를 제조하는 방법은, 식물 종자로부터 물 또는 유기용매를 이용하여 사포닌 조 추출물을 수득하는 제 1 단계; 및 상기 추출물을 산, 염기, 효소 또는 상기 효소를 생산하는 미생물을 이용하여 가수분해함으로써 21-O-안젤로일티아사포제놀(21-O-angeloyltheasapogenol) E3를 분리하는 제 2 단계를 포함하는 것을 특징으로 한다. The method for preparing 21-O-angeloyltheasapogenol E3 represented by the following Chemical Formula 1 according to the present invention is to obtain a crude saponin extract from plant seeds using water or an organic solvent. Stage 1; And a second step of separating 21-O-angeloyltheasapogenol E3 by hydrolyzing the extract with an acid, a base, an enzyme, or a microorganism producing the enzyme. It is done.

[화학식 1][Formula 1]

Figure 112008063533811-PAT00003
Figure 112008063533811-PAT00003

상기 제 1 단계에서, 상기 식물 종자는 녹차 종자인 것을 특징으로 한다.In the first step, the plant seed is characterized in that the green tea seed.

또한, 상기 유기용매로서는 에탄올, 메탄올, 부탄올, 에테르, 에틸아세테이트 및 클로로포름을 포함하는 군으로부터 선택된 하나 이상의 유기용매 또는 이들과 물의 혼합물, 바람직하게는 50 % 에탄올을 사용할 수 있다. As the organic solvent, at least one organic solvent selected from the group consisting of ethanol, methanol, butanol, ether, ethyl acetate and chloroform or a mixture of these and water, preferably 50% ethanol, may be used.

상기 제 2 단계에서, 상기 산은 염산, 황산 및 질산으로 구성되는 군으로부터 선택된 하나 이상의 산, 또는 이들 산과 에탄올, 메탄올 및 부탄올로 구성되는 군으로부터 선택된 하나 이상의 알코올과의 혼합용매를 사용할 수 있다. 이 때, 사용할 수 있는 산의 농도는 0.1N ~ 2N이고, 혼합용매의 알코올 함량은 10 ~ 50%이다. 또한 산을 이용하여 가수분해를 할 때, 반응온도는 50 ~ 100 ℃이고, 반응시간은 0.5 ~ 8 시간임이 바람직하다. In the second step, the acid may be used at least one acid selected from the group consisting of hydrochloric acid, sulfuric acid and nitric acid, or a mixed solvent of these acids with at least one alcohol selected from the group consisting of ethanol, methanol and butanol. At this time, the concentration of acid that can be used is 0.1N ~ 2N, the alcohol content of the mixed solvent is 10 ~ 50%. In addition, when hydrolysis is performed using an acid, the reaction temperature is preferably 50 to 100 ° C., and the reaction time is 0.5 to 8 hours.

상기 염기는 수산화나트륨 및 수산화칼륨으로 구성되는 군으로부터 선택된 하나 이상의 염기, 또는 이들 염기와 에탄올, 메탄올, 부탄올로 구성되는 군으로부터 선택된 하나 이상의 알코올과의 혼합용매를 사용할 수 있다. 이 때, 사용할 수 있는 염기의 농도는 0.1N ~ 2N 이고, 혼합용매의 알코올 함량은 10 ~ 50% 이다. 또한 염기를 이용하여 가수분해를 할 때, 반응온도는 50 ~ 100 ℃이고, 반응시간은 0.5 ~ 24 시간임이 바람직하다. The base may be one or more bases selected from the group consisting of sodium hydroxide and potassium hydroxide, or a mixed solvent of these bases with one or more alcohols selected from the group consisting of ethanol, methanol, butanol. At this time, the concentration of base that can be used is 0.1N ~ 2N, the alcohol content of the mixed solvent is 10 ~ 50%. In addition, when hydrolysis is performed using a base, the reaction temperature is preferably 50 to 100 ° C., and the reaction time is 0.5 to 24 hours.

상기 효소 또는 상기 효소를 생산하는 미생물은 추출물에 함유된 녹차 사포닌의 당 결합을 분해하는 효소 또는 상기 당 결합을 분해하는 효소를 생산하는 미생물로서, 녹차 사포닌의 당부분을 제거하여 21-O-안젤로일티아사포제놀(21-O-angeloyltheasapogenol) E3를 생성하는 것을 특징으로 한다.The enzyme or microorganism producing the enzyme is an enzyme that breaks down the sugar bonds of green tea saponin contained in the extract or an enzyme that breaks down the sugar bond, and removes the sugar portion of green tea saponin to remove 21-O-angelo. It is characterized by producing ylthiasapogenol (21-O-angeloyltheasapogenol) E3.

또한, 상기 효소는 더욱 바람직하게는 글루코시다아제(glucosidase), 아라비 노시다아제(arabinosidase), 람노시다아제(rhamnosidase), 자일로시다아제(xylosidase), 셀룰라아제(cellulase), 헤스페리디나아제(hesperidinase), 나린지나아제(naringinase), 글루쿠로니다아제(glucuronidase), 펙티나아제(pectinase), 갈락토시다아제(galactosidase) 및 아밀로글루코시다아제(amyloglucosidase)로 구성되는 군으로부터 선택된 하나 이상을 사용하는 것을 특징으로 한다.In addition, the enzyme is more preferably glucosidase, arabinosidase, rhamnosidase, xylosidase, cellulase, hesperidinase ), Naringinase, glucuronidase, pectinase, pectinase, galactosidase and amyloglucosidase. It is characterized by using.

또한, 상기 효소를 생산하는 미생물은 아스퍼질러스(aspergillus)속, 바실러스(bacillus)속, 페니실리움(penicillium)속, 리조푸스(rhizopus)속, 리조무코르(rhizomucor)속, 탈라로마이세스(talaromyces)속, 비피도박테리움(bifidobacterium)속, 모르티에렐라(mortierella)속, 크립토코커스(cryptococcus)속 및 마이크로박테리움(microbacterium)속으로 구성되는 군으로부터 선택된 하나 이상을 사용하는 것을 특징으로 한다.In addition, the microorganisms producing the enzyme are aspergillus genus, Bacillus genus, penicillium genus, rhizopus genus, rhizomucor genus, talaomyces (talaromyces), bifidobacterium (genus), mortierella (mortierella), genus Cryptococcus (cryptococcus) and microbacterium (microbacterium), characterized by using one or more selected from the group consisting of do.

이하, 본 발명을 상세히 설명하면 하기와 같다.Hereinafter, the present invention will be described in detail.

상기 제 1 단계에서, 식물, 바람직하게는 녹차 종자로부터 물 또는 유기용매를 이용하여 사포닌 조 추출물을 수득하기 위하여, 식물에 약 1 내지 6 배, 바람직하게는 약 3 배의 물 또는 유기용매를 넣고, 상온에서 1 내지 5 회 교반하면서 추출하여 탈지시킨 다음, 탈지된 식물에 약 1 내지 8 배, 바람직하게는 약 4 배의 물 또는 유기용매를 넣고, 1 내지 5회 환류 추출한 후, 10 내지 20 ℃에서 1 내지 3일간 침적시킨 후, 여과와 원심분리를 통하여 잔사와 여액을 분리하고, 분리된 여액을 감압농축하여 얻은 엑기스를 물에 현탁한 후, 에테르 등을 이용하여 색소를 제 거한 다음, 수층을 유기용매를 사용하여 1 내지 5회 추출한 후, 수득한 유기용매층을 감압농축하여 유기용매 엑기스를 얻은 다음, 이를 소량의 메탄올 등에 녹인 후, 대량의 에틸아세테이트 등을 추가하여 생성된 침전물을 건조시켜, 본 발명의 상기 사포닌 조 추출물을 수득할 수 있다.In the first step, in order to obtain a crude saponin extract using water or an organic solvent from a plant, preferably green tea seed, about 1 to 6 times, preferably about 3 times, water or organic solvent is added to the plant. After extracting and degreasing with stirring at 1 to 5 times at room temperature, and then about 1 to 8 times, preferably about 4 times of water or an organic solvent to the degreased plants, and extracted under reflux 1 to 5 times, 10 to 20 After immersion at 1 ° C. for 3 days, the residue and the filtrate were separated through filtration and centrifugation, and the extract obtained by concentrating the separated filtrate under reduced pressure was suspended in water, and then the pigment was removed using ether or the like. The aqueous layer was extracted 1 to 5 times using an organic solvent, and the obtained organic solvent layer was concentrated under reduced pressure to obtain an organic solvent extract. After dissolving it in a small amount of methanol, a large amount of ethyl acetate was added. And by drying the resulting precipitate, it is possible to afford the crude saponin extract of the present invention.

상기 제 2 단계에서, 상기 사포닌 조추출물을 산, 염기, 효소 또는 상기 효소를 생산하는 미생물을 이용하여 가수분해하여 21-O-안젤로일티아사포제놀(21-O-angeloyltheasapogenol) E3를 제조한다. 이 때, 산을 이용 시에는 사포닌 조 추출물에 0.1N ~ 2N 농도, 바람직하게는 1N 농도의 산, 또는 산 및 알코올의 혼합용매(바람직하게는 50% 에탄올 혼합용매)를 가한 후, 50 내지 100 ℃, 바람직하게는 80 ℃ 수욕조에서 1 시간 동안 가열 환류시켜 가수분해한다. 또한, 염기를 이용 시에는 식물 추출물을 녹인 후, 0.1N ~ 2N 농도, 바람직하게는 1N 농도의 염기, 또는 염기 및 알코올의 혼합용매(바람직하게는 50% 부탄올 혼합용매)를 가해 50 내지 100 ℃, 바람직하게는 100 ℃ 수욕조에서 12 시간 동안 가열 환류시켜 가수분해한다. 또한, 효소를 이용 시에는 식물 추출물을 5 내지 20 배, 바람직하게는 약 10 배의 산성완충용액에 용해시킨 다음, 효소를 첨가하여 약 37 ℃ 수욕상에서 약 40 내지 55 시간, 바람직하게는 약 48시간 동안 교반하면서, 박층크로마토그래피로 기질의 소거율을 확인하여 기질이 완전히 소실되면 열수(80 ~ 100 ℃) 중에서 5 내지 15 분 동안 가열하여 반응을 종료시켜 가수분해한다. 미생물을 활용 시에는 식물 추출물을 5 내지 10배, 바람직하게는 약 10배의 이온수에 용해시킨 후 121℃에서 30분간 멸균하여 30 ℃로 냉각한 후 미리 배양된 미생물을 액체량 대비 5~10%로 접 종하여 30 ℃에서 2 내지 5일 바람직하게는 5일 동안 배양 시킨 후 박층 크로마토그래피로 기질의 소거율을 확인하여 기질이 완전히 소실되면 배양액을 5,000 내지 10,000 rpm으로 원심분리하여 회수한 침전물을 증류수로 3회 세척 후 원심분리하여 침전물을 얻는다. In the second step, the saponin crude extract is hydrolyzed using an acid, a base, an enzyme, or a microorganism producing the enzyme to prepare 21-O-angeloyltheasapogenol E3. At this time, when using an acid, a saponin crude extract is added with a concentration of 0.1N to 2N, preferably 1N, or a mixed solvent of acid and alcohol (preferably 50% ethanol mixed solvent), and then 50 to 100. The hydrolysis is carried out by heating to reflux for 1 hour in a water bath at 80 ° C., preferably at 80 ° C. In addition, when the base is used, the plant extract is dissolved, and then a base of 0.1N to 2N concentration, preferably 1N concentration, or a mixed solvent of a base and an alcohol (preferably 50% butanol mixed solvent) is added to 50 to 100 ° C. Hydrolysis is preferably carried out by heating to reflux for 12 hours in a 100 ° C. water bath. In addition, when the enzyme is used, the plant extract is dissolved in an acid buffer solution of 5 to 20 times, preferably about 10 times, and then the enzyme is added, about 40 to 55 hours in a water bath of about 37 ° C., preferably about 48 hours. While stirring for an hour, the substrate was confirmed by thin layer chromatography, and when the substrate was completely lost, it was hydrolyzed by heating in hot water (80-100 ° C.) for 5-15 minutes to terminate the reaction. When using microorganisms, plant extracts are dissolved in 5 to 10 times, preferably about 10 times, ionized water, sterilized at 121 ° C. for 30 minutes, cooled to 30 ° C., and then 5 to 10% After incubation at 30 ° C. for 2 to 5 days, preferably 5 days, the substrate was confirmed by thin layer chromatography to confirm the scavenging rate of the substrate. When the substrate was completely lost, the precipitate was recovered by centrifugation at 5,000 to 10,000 rpm. After washing three times with distilled water and centrifuged to obtain a precipitate.

상기와 같이 산, 염기, 효소, 또는 상기 효소를 생산하는 미생물을 이용하여 가수분해 한 후, 반응액을 감압농축하여 용매를 제거하고, 잔사에 알코올을 가하여 1 내지 5회 교반시킨 후, 침전된 염들을 여과를 통하여 제거하고, 여과된 여액을 감압농축하여 조 생성물을 수득하고, 수득된 조 생성물을 실리카겔 컬럼 크로마토그래피(클로로포름:메탄올 = 8:1~4:1)로 분리하여 21-O-안젤로일티아사포제놀(21-O-angeloyltheasapogenol) E3를 수득할 수 있다. After hydrolysis using an acid, a base, an enzyme, or a microorganism producing the enzyme as described above, the reaction solution was concentrated under reduced pressure to remove the solvent, and stirred 1 to 5 times by adding alcohol to the residue, followed by precipitation. The salts were removed through filtration, and the filtrate was concentrated under reduced pressure to give a crude product. The crude product was separated by silica gel column chromatography (chloroform: methanol = 8: 1-4: 1) to obtain 21-O-. Angeloylthiasapogenol (21-O-angeloyltheasapogenol) E3 can be obtained.

이하, 실시예 및 실험예를 통하여 본 발명을 더욱 상세히 설명하지만, 본 발명이 이들 예로만 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples and Experimental Examples, but the present invention is not limited only to these examples.

[실시예 1] 녹차 종자 추출물의 제조Example 1 Preparation of Green Tea Seed Extract

녹차 종자 2 ㎏에 헥산 6 ℓ를 넣고, 상온에서 3회 교반 추출하여 탈지시킨 다음, 탈지된 녹차 종자 1 kg에 50 % 에탄올 4 ℓ를 넣고, 3회 환류 추출한 후, 15 ℃에서 1일간 침적시켰다. 그 후, 여과포 여과와 원심분리를 통해 잔사와 여액을 분리하고, 분리된 여액을 감압농축하여 얻은 엑기스를 물에 현탁한 후, 에테르 1 ℓ로 5회 추출하여 색소를 제거하고, 수층을 1-부탄올 500 ㎖로 3회 추출하였다. 이로부터 얻은 총 1-부탄올층을 감압농축하여 1-부탄올 엑기스를 얻고, 이를 소량의 메탄올에 녹인 다음, 대량의 에틸아세테이트에 추가하여, 생성된 침전물을 건조함으로써, 녹차 종자 추출물 300 g을 수득하였다.6 kg of hexane was added to 2 kg of green tea seeds, stirred and extracted three times at room temperature, and then degreased. Then, 4 l of 50% ethanol was added to 1 kg of degreased green tea seeds, and refluxed three times. . Thereafter, the residue and the filtrate were separated through filter cloth filtration and centrifugation, and the extract obtained by concentrating the separated filtrate under reduced pressure was suspended in water, and then extracted five times with 1 L of ether to remove the pigment, and the aqueous layer was 1-. Extracted three times with 500 ml of butanol. The total 1-butanol layer thus obtained was concentrated under reduced pressure to obtain 1-butanol extract, which was dissolved in a small amount of methanol and then added to a large amount of ethyl acetate, and the resulting precipitate was dried to obtain 300 g of green tea seed extract. .

[실시예 2] 산 가수분해 방법에 의한 21-O-안젤로일티아사포제놀(21-O-angeloyltheasapogenol) E3의 제조Example 2 Preparation of 21-O-angeloylthiasapogenol (21-O-angeloyltheasapogenol) E3 by Acid Hydrolysis Method

상기 실시예 1에서 수득한 녹차 종자 추출물 10 g에 20배(v/w)의 1 N HCl-50 % 메탄올 용액(v/v)을 가하고, 80 ℃ 수욕조에서 8시간 동안 가열 환류시켜, 녹차 종자 조 사포닌에 결합된 당들을 가수분해시켰다. 반응액을 감압농축하여 용매를 제거하고, 잔사에 에탄올(200 ㎖)을 가해 교반시킨 후(3회), 침전된 염들을 여과를 통해 제거한 다음, 여과된 여액을 감압농축하여 조 생성물을 수득한 후, 수득된 조생성물을 실리카겔 컬럼 크로마토그래피(클로로포름:메탄올 = 7:1~3:1)로 분리하여 21-O-안젤로일티아사포제놀(21-O-angeloyltheasapogenol) E3 0.55 g을 수득하였다.20 g (v / w) of 1 N HCl-50% methanol solution (v / v) was added to 10 g of the green tea seed extract obtained in Example 1, and heated to reflux for 8 hours in an 80 ° C. water bath. Sugars bound to seed crude saponins were hydrolyzed. The reaction solution was concentrated under reduced pressure to remove the solvent, and the residue was stirred by adding ethanol (200 mL) to the residue (three times). The precipitated salts were removed by filtration, and the filtrate was concentrated under reduced pressure to give a crude product. The crude product obtained was then separated by silica gel column chromatography (chloroform: methanol = 7: 1-3: 1) to give 0.55 g of 21-O-angeloyltheasapogenol E3.

[실시예 3] 염기 가수분해 방법에 의한 21-O-안젤로일티아사포제놀(21-O-angeloyltheasapogenol) E3 제조Example 3 Preparation of 21-O-angeloylthiasapogenol (21-O-angeloyltheasapogenol) E3 by Base Hydrolysis Method

상기 실시예 1에서 수득한 녹차 종자 추출물 10 g을 건조피리딘(500 ㎖)에 녹이고, 여기에 소디움 메톡사이드(sodium methoxide)(powder, 10 g)를 가해 유욕상에서 8시간 동안 환류 반응시켜, 녹차 종자 사포닌에 결합된 당들을 가수분해시 킨 다음, 반응액을 감압농축하여 용매를 제거하고, 잔사에 에탄올(200 ㎖)을 가해 교반시킨 후(3회), 침전된 염들을 여과를 통해 제거하였다. 여과된 여액을 감압농축하여 조 생성물을 수득하였으며, 수득된 얻은 조 생성물을 실리카겔 컬럼 크로마토그래피(클로로포름-메탄올=8:1~4:1)로 분리하여 21-O-안젤로일티아사포제놀(21-O-angeloyltheasapogenol) E3 0.35 g을 수득하였다.10 g of the green tea seed extract obtained in Example 1 was dissolved in dry pyridine (500 ml), and sodium methoxide (powder, 10 g) was added thereto, and the mixture was refluxed for 8 hours on an oil bath. After the sugars bound to saponin were hydrolyzed, the reaction solution was concentrated under reduced pressure to remove the solvent, and ethanol (200 mL) was added to the residue, followed by stirring (three times). The precipitated salts were removed by filtration. The filtrate was concentrated under reduced pressure to give a crude product, and the obtained crude product was separated by silica gel column chromatography (chloroform-methanol = 8: 1 to 4: 1) to obtain 21-O-angeloylthiasapogenol (21 0.35 g of -O-angeloyltheasapogenol) E3 was obtained.

[실시예 4] 효소분해 방법에 의한 21-O-안젤로일티아사포제놀(21-O-angeloyltheasapogenol) E3 제조Example 4 Preparation of 21-O-angeloylthiasapogenol (21-O-angeloyltheasapogenol) E3 by enzymatic digestion

상기 실시예 1에서 수득한 녹차 씨 추출물 10 g을 100 ㎖의 0.1 M 초산완충용액(pH 4.5)에 용해시키고, 여기에 효소 2.5 g(헤스페리디나제 0.5 g, 나린지나제 0.5 g, 셀룰라제 0.5 g, β-글루쿠로니다제 0.2 g, β-갈락토시다제 0.5 g, 아밀로글루코시다제 0.3 g ; Sigma사 제조)을 첨가하여 37 ℃ 수욕상에서 48 시간 동안 교반시키면서, 박층크로마토그래피에 의해 주기적으로 확인하고, 녹차 사포닌이 소실되면 열수(80 ~ 100 ℃) 중에서 10분간 가열하여 반응을 종료시킨 후, 반응액을 감압농축하여 용매를 제거하고, 잔사에 에탄올(200㎖)을 가해 교반시킨 다음(3회), 침전물을 여과를 통해 제거한 후, 여과된 여액을 감압농축하여 조 생성물을 수득하였다. 수득한 조 생성물을 실리카겔 컬럼 크로마토그래피(클로로포름:메탄올= 8:1~4:1)로 분리하여 21-O-안젤로일티아사포제놀(21-O-angeloyltheasapogenol) E3 1.02 g을 얻었다.10 g of the green tea seed extract obtained in Example 1 was dissolved in 100 ml of 0.1 M acetic acid buffer solution (pH 4.5), and 2.5 g of enzyme (0.5 g of hesperidinase, 0.5 g of naringinase, cellulase) was added thereto. 0.5 g, β-glucuronidase 0.2 g, β-galactosidase 0.5 g, amyloglucosidase 0.3 g; manufactured by Sigma) was added and thin layer chromatography was stirred for 48 hours in a 37 ° C water bath. After checking periodically, the green tea saponin disappeared and heated in hot water (80-100 ° C.) for 10 minutes to complete the reaction. The reaction solution was concentrated under reduced pressure to remove the solvent, and ethanol (200 mL) was added to the residue. After stirring (three times), the precipitate was removed by filtration, and the filtrate was concentrated under reduced pressure to give a crude product. The obtained crude product was separated by silica gel column chromatography (chloroform: methanol = 8: 1-4: 1) to obtain 1.02 g of 21-O-angeloyltheasapogenol E3.

[실시예 5] 미생물을 활용한 21-O-안젤로일티아사포제놀(21-O-angeloyltheasapogenol) E3 제조Example 5 21-O-angeloyltheasapogenol E3 Preparation Using Microorganisms

상기 실시예 2에서 수득한 녹차 잎 추출물 10 g을 100 ㎖의 이온수에 용해 시키고, 121℃에서 30분간 멸균하여 30 ℃로 냉각한 후 미리 배양된 아스퍼질러스 니거(Aspergillus niger) KCCM 11885를 액체량 대비 5~10% 로 접종하여 30 ℃에서 5일 동안 배양 시킨 후 박층 크로마토그래피로 기질의 소거율을 확인하여 기질이 완전히 소실된 것을 확인하고 배양액을 5,000 내지 10,000 rpm으로 원심분리하여 회수한 침전물을 증류수로 3회 세척 다음 원심분리하여 침전물을 얻었다. 이 침전물에 에탄올(200㎖)을 가해 교반시킨 다음(3회), 침전물을 여과를 통해 제거한 후, 여과된 여액을 감압농축하여 조 생성물을 수득하였다. 수득한 조 생성물을 실리카겔 컬럼 크로마토그래피(클로로포름:메탄올= 8:1~4:1)로 분리하여 21-O-안젤로일티아사포제놀(21-O-angeloyltheasapogenol) E3 0.72 g을 얻었다.10 g of the green tea leaf extract obtained in Example 2 was dissolved in 100 ml of ionized water, sterilized at 121 ° C. for 30 minutes, cooled to 30 ° C., and then pre-cultured Aspergillus niger KCCM 11885 in liquid quantity. 5-10% of the inoculum was incubated at 30 ° C. for 5 days, followed by thin layer chromatography to confirm the elimination of the substrate to confirm that the substrate was completely lost. The precipitate was recovered by centrifuging the culture at 5,000 to 10,000 rpm. Washed three times with distilled water and then centrifuged to obtain a precipitate. Ethanol (200 mL) was added to the precipitate, followed by stirring (three times). The precipitate was removed by filtration, and the filtrate was concentrated under reduced pressure to give a crude product. The obtained crude product was separated by silica gel column chromatography (chloroform: methanol = 8: 1-4: 1) to obtain 0.72 g of 21-O-angeloyltheasapogenol E3.

[실험예 1] 21-O-안젤로일티아사포제놀(21-O-angeloyltheasapogenol) E3의 동정Experimental Example 1 Identification of 21-O-angeloyltheasapogenol E3

상기 실시예 2 내지 5에서 제조된 생성물은 하기와 같은 특성을 나타내므로 21-O-안젤로일티아사포제놀(21-O-angeloyltheasapogenol) E3로 동정(Varian Gemini 2000 300MHz, Varian사)하였다.The products prepared in Examples 2 to 5 exhibited the following characteristics and were identified as 21-O-angeloyltheasapogenol E3 (Varian Gemini 2000 300MHz, Varian).

< 21-O-안젤로일티아사포제놀 E3의 물리화학적 성상 >Physical and chemical properties of 21-O-angeloylthiasapogenol E3

성상 : 백색의 미세 결정Appearance: White fine crystal

분자량 : 586.7 Molecular Weight: 586.7

Figure 112008063533811-PAT00004
Figure 112008063533811-PAT00004

탄소carbon δHδH δCδC deptdept 1One 1.12, 1.75(2H)1.12, 1.75 (2H) 39.7139.71 CH2 CH 2 22 1.70(2H)1.70 (2H) 27.1527.15 CH2 CH 2 33 3.78(1H, t)3.78 (1 H, t) 72.9772.97 CHCH 44 -- 56.9256.92 CC 55 1.34(1H)1.34 (1 H) 48.6748.67 CHCH 66 0.91(2H, m)0.91 (2H, m) 21.8621.86 CH2 CH 2 77 1.67(2H)1.67 (2 H) 33.4633.46 CH2 CH 2 88 -- 41.4341.43 CC 99 1.80(1H)1.80 (1 H) 48.1148.11 CHCH 1010 -- 37.0237.02 CC 1111 1.95(2H)1.95 (2 H) 21.7421.74 CH2 CH 2 1212 5.35(1H, brs)5.35 (1H, brs) 124.57124.57 CHCH 1313 -- 143.79143.79 CC 1414 -- 42.7042.70 CC 1515 1.36, 1.79(2H)1.36, 1.79 (2H) 34.7334.73 CH2 CH 2 1616 4.14(1H, brs)4.14 (1H, brs) 68.8968.89 CHCH 1717 -- 48.6348.63 CC 1818 2.59(1H, t)2.59 (1 H, t) 41.1541.15 CHCH 1919 1.12, 2.47(1H each, dd-like)1.12, 2.47 (1H each, dd-like) 48.4748.47 CH2 CH 2 2020 -- 36.7336.73 CC 2121 5.58(1H, d, 10.1 Hz)5.58 (1H, d, 10.1 Hz) 82.4782.47 CHCH 2222 3.99(1H, d, 10.1 Hz)3.99 (1H, d, 10.1 Hz) 74.1174.11 CHCH 2323 9.31(1H, s)9.31 (1 H, s) 208.73208.73 CHCH 2424 1.13(3H, s)1.13 (3H, s) 9.569.56 CH3 CH 3 2525 1.12(3H, s)1.12 (3H, s) 16.4516.45 CH3 CH 3 2626 0.95(3H, s)0.95 (3H, s) 17.4917.49 CH3 CH 3 2727 1.48(3H, s)1.48 (3H, s) 27.7427.74 CH3 CH 3 2828 3.20, 3.33(1H each, dd, 10.3 Hz)3.20, 3.33 (1H each, dd, 10.3 Hz) 66.5766.57 CH2 CH 2 2929 0.85(3H, s)0.85 (3H, s) 30.0330.03 CH3 CH 3 3030 1.13(3H, s)1.13 (3H, s) 20.4420.44 CH3 CH 3 21-O-Ang21-O-Ang 1'One' -- 170.57170.57 CC 2'2' -- 130.07130.07 CC 3'3 ' 6.07(1H, dq like)6.07 (1H, dq like) 138.07138.07 CHCH 4'4' 1.97(3H, dd, 8.63 Hz)1.97 (3H, doublet, 8.63 Hz) 16.1516.15 CH3 CH 3 5'5 ' 1.92(3H, s)1.92 (3 H, s) 21.1221.12 CH3 CH 3

[실험예 2] 가수분해(효소분해) 후 21-O-안젤로일티아사포제놀(21-O-angeloyltheasapogenol) E3의 생성 확인[Experimental Example 2] Confirmation of 21-O-angeloyltheasapogenol E3 Production after Hydrolysis (enzymatic degradation)

녹차 종자 추출물을 상기 실시예 1의 방법으로 제조한 다음, 상기 실시예 4의 방법으로 효소분해 반응을 진행시킨 후, 효소분해 반응시의 변화를 고속액체 크 로마토그래피를 이용하여 측정하였다. 녹차 종자 추출물의 효소반응 후의 21-O-안젤로일티아사포제놀(21-O-angeloyltheasapogenol) E3 함량을 측정한 결과를 도 1에 나타내었고 이를 분리하여 21-O-안젤로일티아사포제놀(21-O-angeloyltheasapogenol) E3를 제조한 결과를 도 2에 나타내었다.After the green tea seed extract was prepared by the method of Example 1, and then subjected to the enzymatic reaction by the method of Example 4, the change during the enzymatic reaction was measured by high performance liquid chromatography. The result of measuring the content of 21-O-angeloyltheasapogenol E3 after enzymatic reaction of green tea seed extract is shown in FIG. 1 and it was isolated and 21-O-angeloylthiasapogenol (21- The result of preparing O-angeloyltheasapogenol) E3 is shown in FIG. 2.

그 결과, 도 1 및 도 2에 나타낸 바처럼, 효소반응 후 녹차 종자 사포닌 추출물에서21-O-안젤로일티아사포제놀(21-O-angeloyltheasapogenol) E3가 전환되었음을 알 수 있었다.As a result, as shown in Figures 1 and 2, it was found that 21-O-angeloyltheasapogenol E3 was converted in the green tea seed saponin extract after the enzyme reaction.

도 1은 녹차 종자 추출물을 효소로 가수분해하여 21-O-안젤로일티아사포제놀 E3의 생성을 측정한 것을 나타낸 것이다.Figure 1 shows the measurement of the production of 21-O-angeloylthiasapogenol E3 by hydrolyzing the green tea seed extract with an enzyme.

도 2는 녹차 종자 추출물의 가수분해물로부터 21-O-안젤로일티아사포제놀 E3를 분리해낸 것을 측정한 것을 나타낸 것이다.Figure 2 shows the measurement of the separation of 21-O-angeloylthiasapogenol E3 from the hydrolyzate of the green tea seed extract.

Claims (7)

식물 종자로부터 물 또는 유기용매를 이용하여 사포닌을 함유하는 추출물을 수득하는 제 1 단계; 및 A first step of obtaining an extract containing saponin from water or organic solvent from a plant seed; And 상기 추출물을 산, 염기, 효소 또는 상기 효소를 생산하는 미생물을 이용하여 가수분해함으로써 하기 화학식 1로 표현되는 21-O-안젤로일티아사포제놀(21-O-angeloyltheasapogenol) E3를 분리하는 제 2 단계;The second step of separating the 21-O-angeloyltheasapogenol E3 represented by the following formula 1 by hydrolysis of the extract using an acid, a base, an enzyme or a microorganism producing the enzyme ; 를 포함하는 21-O-안젤로일티아사포제놀 E3를 제조하는 방법. Method for producing a 21-O-angeloylthiasapogenol E3 comprising a. [화학식 1][Formula 1]
Figure 112008063533811-PAT00005
Figure 112008063533811-PAT00005
제 1항에 있어서, 상기 식물 종자는 녹차 종자임을 특징으로 하는 21-O-안젤로일티아사포제놀 E3를 제조하는 방법.The method of claim 1, wherein the plant seed is a green tea seed. 제 1항에 있어서, 상기 유기용매는 에탄올, 메탄올, 부탄올, 에테르, 에틸아세테이트 및 클로로포름을 포함하는 군으로부터 선택된 하나 이상의 유기용매 또는 이들과 물의 혼합물임을 특징으로 하는 21-O-안젤로일티아사포제놀 E3를 제조하는 방법.The method of claim 1, wherein the organic solvent is at least one organic solvent selected from the group consisting of ethanol, methanol, butanol, ether, ethyl acetate and chloroform or a mixture of water and 21-O-angeloylthiasapogenol How to make E3. 제 1항에 있어서, 상기 산은 염산, 황산 및 질산으로 구성되는 군으로부터 선택된 하나 이상의 산, 또는 이들 산과 에탄올, 메탄올 및 부탄올로 구성되는 군으로부터 선택된 하나 이상의 알코올과의 혼합용매임을 특징으로 하는 21-O-안젤로일티아사포제놀 E3를 제조하는 방법.The method of claim 1, wherein the acid is at least one acid selected from the group consisting of hydrochloric acid, sulfuric acid and nitric acid, or a mixed solvent of these acids with at least one alcohol selected from the group consisting of ethanol, methanol and butanol. Process for preparing O-angeloylthiasapogenol E3. 제 1항에 있어서, 상기 염기는 수산화나트륨 및 수산화칼륨으로 구성되는 군으로부터 선택된 하나 이상의 염기, 또는 이들 염기와 에탄올, 메탄올, 부탄올로 구성되는 군으로부터 선택된 하나 이상의 알코올과의 혼합용매임을 특징으로 하는 21-O-안젤로일티아사포제놀 E3를 제조하는 방법.The method of claim 1, wherein the base is at least one base selected from the group consisting of sodium hydroxide and potassium hydroxide, or a mixed solvent of these bases with at least one alcohol selected from the group consisting of ethanol, methanol, butanol Process for preparing 21-O-angeloylthiasapogenol E3. 제 1항에 있어서, 상기 효소는 글루코시다아제(glucosidase), 아라비노시다아제(arabinosidase), 람노시다아제(rhamnosidase), 자일로시다아제(xylosidase), 셀룰라아제(cellulase), 헤스페리디나아제(hesperidinase), 나린지나아제(naringinase), 글루쿠로니다아제(glucuronidase), 펙티나아제(pectinase), 갈락토시다아제(galactosidase) 및 아밀로글루코시다아제(amyloglucosidase)로 구성되는 군으로부터 선택된 하나 이상임을 특징으로 하는 21-O-안젤로일티아사포제놀 E3를 제조하는 방법.The enzyme of claim 1, wherein the enzyme is glucosidase, arabinosidase, rhamnosidase, xylosidase, cellulase, hesperidinase ), Naringinase, glucuronidase, pectinase, pectinase, galactosidase and amyloglucosidase. Characterized by a method for preparing 21-O-angeloylthiasapogenol E3. 제 1항에 있어서, 상기 효소를 생산하는 미생물은 아스퍼질러스(aspergillus)속, 바실러스(bacillus)속, 페니실리움(penicillium)속, 리조푸스(rhizopus)속, 리조무코르(rhizomucor)속, 탈라로마이세스(talaromyces)속, 비피도박테리움(bifidobacterium)속, 모르티에렐라(mortierella)속, 크립토코커스(cryptococcus)속 및 마이크로박테리움(microbacterium)속으로 구성되는 군으로부터 선택된 하나 이상임을 특징으로 하는 21-O-안젤로일티아사포제놀 E3를 제조하는 방법.According to claim 1, wherein the microorganism producing the enzyme is genus Aspergillus, Bacillus, Bacillus, Penicillium, Rhizopus, Rhizomucor, One or more selected from the group consisting of genus talomyces, genus bifidobacterium, genus mortierella, genus cryptoococcus, and genus microbacterium Method for producing 21-O-angeloylthiasapogenol E3 according to the present invention.
KR1020080088127A 2008-09-08 2008-09-08 Method for preparing green tea saponin, 21-O-angeloyltheasapogenol E3 KR101415995B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020080088127A KR101415995B1 (en) 2008-09-08 2008-09-08 Method for preparing green tea saponin, 21-O-angeloyltheasapogenol E3

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020080088127A KR101415995B1 (en) 2008-09-08 2008-09-08 Method for preparing green tea saponin, 21-O-angeloyltheasapogenol E3

Publications (2)

Publication Number Publication Date
KR20100029369A true KR20100029369A (en) 2010-03-17
KR101415995B1 KR101415995B1 (en) 2014-07-08

Family

ID=42179595

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020080088127A KR101415995B1 (en) 2008-09-08 2008-09-08 Method for preparing green tea saponin, 21-O-angeloyltheasapogenol E3

Country Status (1)

Country Link
KR (1) KR101415995B1 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102746366A (en) * 2012-06-26 2012-10-24 岳西县未来农业发展有限公司 Method for extracting tea saponin from camellia oleifera cake
CN102942604A (en) * 2012-11-19 2013-02-27 浙江理工大学 Method for separation and purification of tea saponin through foam
CN103012544A (en) * 2012-12-31 2013-04-03 广西师范大学 Method for extracting saponin and polysaccharide from tea-seed pancake
KR101289077B1 (en) * 2011-06-13 2013-07-22 서동진 A process for extracting saponins from green tea seeds
KR20130118507A (en) * 2012-04-20 2013-10-30 (주)아모레퍼시픽 Skin external composition for anti-aging comprising 21-o-angeloyltheasapogenol e3 from green tea seed
CN103980340A (en) * 2014-05-21 2014-08-13 湖北宜恒茶油产业科技有限责任公司 Method for preparing high-purity tea saponin by using enzymic method together with membrane technique
WO2015005512A1 (en) * 2013-07-11 2015-01-15 주식회사 아모레퍼시픽 Composition for antioxidation or skin whitening containing 21-o-angeloyltheasapogenol e3 ingredient derived from green tea seed
WO2015005511A1 (en) * 2013-07-11 2015-01-15 주식회사 아모레퍼시픽 Antiaging skin preparation composition containing 21-o-angeloyltheasapogenol e3 ingredient derived from green tea seed
WO2015030422A1 (en) * 2013-08-30 2015-03-05 (주)아모레퍼시픽 Composition for accelerating hair restoration or hair growth, comprising 21-o-angeloyltheasapogenol e3
CN105461779A (en) * 2015-11-25 2016-04-06 中国林业科学研究院亚热带林业研究所 Low-cost tea-saponin-continuous-extraction raw material pretreatment process
CN107868112A (en) * 2017-12-08 2018-04-03 林燕 A kind of preparation method of the natural high-purity tea saponin of high-effective cleansing
CN114950480A (en) * 2022-07-06 2022-08-30 西北大学 Carbon-based solid acid catalyst and method for preparing tea sapogenin by catalyzing tea saponin through carbon-based solid acid catalyst

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102429834B1 (en) 2015-03-31 2022-08-05 (주)아모레퍼시픽 Composition comprising theasapogenol derivatives

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101289077B1 (en) * 2011-06-13 2013-07-22 서동진 A process for extracting saponins from green tea seeds
KR101865207B1 (en) * 2012-04-20 2018-06-08 (주)아모레퍼시픽 Skin external composition for anti-aging comprising 21-O-angeloyltheasapogenol E3 from green tea seed
KR20130118507A (en) * 2012-04-20 2013-10-30 (주)아모레퍼시픽 Skin external composition for anti-aging comprising 21-o-angeloyltheasapogenol e3 from green tea seed
CN102746366A (en) * 2012-06-26 2012-10-24 岳西县未来农业发展有限公司 Method for extracting tea saponin from camellia oleifera cake
CN102942604A (en) * 2012-11-19 2013-02-27 浙江理工大学 Method for separation and purification of tea saponin through foam
CN103012544A (en) * 2012-12-31 2013-04-03 广西师范大学 Method for extracting saponin and polysaccharide from tea-seed pancake
WO2015005512A1 (en) * 2013-07-11 2015-01-15 주식회사 아모레퍼시픽 Composition for antioxidation or skin whitening containing 21-o-angeloyltheasapogenol e3 ingredient derived from green tea seed
WO2015005511A1 (en) * 2013-07-11 2015-01-15 주식회사 아모레퍼시픽 Antiaging skin preparation composition containing 21-o-angeloyltheasapogenol e3 ingredient derived from green tea seed
CN105407895B (en) * 2013-07-11 2019-03-12 株式会社爱茉莉太平洋 Anti-aging Dermatologic preparation composition is used for containing the 21-O- Radix Angelicae Sinensis acyl theasapogenol E3 ingredient from green tea seed
CN105377263A (en) * 2013-07-11 2016-03-02 株式会社爱茉莉太平洋 Composition for antioxidation or skin whitening containing 21-O-angeloyltheasapogenol E3 ingredient derived from green tea seed
CN105407895A (en) * 2013-07-11 2016-03-16 株式会社爱茉莉太平洋 Antiaging skin preparation composition containing 21-O-angeloyltheasapogenol E3 ingredient derived from green tea seed
JP2016528203A (en) * 2013-07-11 2016-09-15 株式会社アモーレパシフィックAmorepacific Corporation Anti-aging skin external preparation composition containing 21-O-angeloylteasapogenol E3 component derived from green tea seeds
CN105377263B (en) * 2013-07-11 2020-05-29 株式会社爱茉莉太平洋 Antioxidant or skin whitening composition containing 21-O-angeloyltheasapogenol E3 derived from green tea seed
JP2016528204A (en) * 2013-07-11 2016-09-15 株式会社アモーレパシフィックAmorepacific Corporation Antioxidant or skin whitening composition containing 21-O-angeloylteasapogenol E3 component derived from green tea seeds
JP2016529287A (en) * 2013-08-30 2016-09-23 株式会社アモーレパシフィックAmorepacific Corporation Hair growth or hair growth promoting composition containing 21-O-angeloyl theasapogenol E3
CN105636593A (en) * 2013-08-30 2016-06-01 株式会社爱茉莉太平洋 Composition for accelerating hair restoration or hair growth, comprising 21-o-angeloyltheasapogenol E3
CN105636593B (en) * 2013-08-30 2018-09-18 株式会社爱茉莉太平洋 Including the hair tonic of 21-O- angeloyl groups theasapogenols E3 or educating hair composition for promoting
WO2015030422A1 (en) * 2013-08-30 2015-03-05 (주)아모레퍼시픽 Composition for accelerating hair restoration or hair growth, comprising 21-o-angeloyltheasapogenol e3
CN103980340A (en) * 2014-05-21 2014-08-13 湖北宜恒茶油产业科技有限责任公司 Method for preparing high-purity tea saponin by using enzymic method together with membrane technique
CN105461779A (en) * 2015-11-25 2016-04-06 中国林业科学研究院亚热带林业研究所 Low-cost tea-saponin-continuous-extraction raw material pretreatment process
CN107868112A (en) * 2017-12-08 2018-04-03 林燕 A kind of preparation method of the natural high-purity tea saponin of high-effective cleansing
CN114950480A (en) * 2022-07-06 2022-08-30 西北大学 Carbon-based solid acid catalyst and method for preparing tea sapogenin by catalyzing tea saponin through carbon-based solid acid catalyst
CN114950480B (en) * 2022-07-06 2023-06-27 西北大学 Carbon-based solid acid catalyst and method for preparing tea sapogenin by catalyzing tea saponin by using carbon-based solid acid catalyst

Also Published As

Publication number Publication date
KR101415995B1 (en) 2014-07-08

Similar Documents

Publication Publication Date Title
KR101415995B1 (en) Method for preparing green tea saponin, 21-O-angeloyltheasapogenol E3
KR100716887B1 (en) Manufacturing method of Kaempferol
EP1254131B1 (en) Extraction of flavonoids
KR20080033705A (en) Process for preparing kaempferol-3-o-rutinoside
US7507423B2 (en) Extraction of flavonoids
Baik et al. Biotransformation of catechin and extraction of active polysaccharide from green tea leaves via simultaneous treatment with tannase and pectinase
CN108904587A (en) The method for extracting separation blue or green money willow flavones
KR101089739B1 (en) Method of preparing a pure liquiritigenin from Glycyrrhiza Radix in high yield and functional cosmetic compostion comprising the liquiritigenin
KR100768681B1 (en) Process for producing aglycon by using diglycosidase and flavor-improved food containing the aglycon
JP4571575B2 (en) Proanthocyanidin-containing tea beverage and method for producing the same
KR20100056422A (en) Cosmetic compositions for whitening skin comprising extracts from mulberry root hydrolyzed by enzymes
CN105189526B (en) Method for preparing coumestrol or coumestrol
CN116987056A (en) Method for extracting dihydroquercetin from larch
Nor et al. Enhancement and bioavailability of phenolic content in Kappaphycus alvarezii through solid substrate fermentation
KR102407042B1 (en) Method for producing Opuntia humifusa fermented solution using lactic acid bacteria and enzyme
KR101529709B1 (en) Method for production of soybean isoflavone aglycone
KR20160121758A (en) Preparation method of extract comprising flavonoid aglycone derived from citron seed, and cosmetic composition comprising the same
KR101525956B1 (en) preparation method of quercetin or isoquecitrin using β-glucosidase
KR20080049413A (en) Preparing method of astragalin
KR102591931B1 (en) Enzymatically treated Achillea millefolium
WO2005045051A1 (en) Baicalin de-glycosylation
Liu et al. Production and biological activity of β-1, 3-xylo-oligosaccharides using xylanase from Caulerpa lentillifera
KR20240043886A (en) Green tea peptide and composition for anti-inflammation comprising the same
CN116585381A (en) Initial extraction method of rose enzymolysis antioxidation active substance
CN116732117A (en) Application of Hungatella strain in biotransformation of flavonoid glycoside

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20170628

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20180702

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20190701

Year of fee payment: 6